Clinical Trial Update: Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed the safety and tolerability of valsartan in children aged 6 to 17 with hypertension or chronic kidney disease. The study is completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-04-21